| John Clark Osborn, MD | |
|
310 2nd Ave Sw, 107-b, Miami, OK 74354-6743 | |
| (918) 540-7730 | |
| (918) 540-7797 |
| Full Name | John Clark Osborn |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 41 Years |
| Location | 310 2nd Ave Sw, Miami, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629044334 | NPI | - | NPPES |
| 200468380O | Medicaid | OK | |
| 500156005 | Medicaid | MO | |
| 207709718 | Medicaid | MO | |
| 100096540A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 15646 (Oklahoma) | Secondary |
| 207Q00000X | Family Medicine | 15646 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Northeast Oklahoma | Broken arrow, OK | Home health agency |
| Integris Miami Hospital | Miami, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integris Ambulatory Care Corporation | 2365408465 | 382 |
| Integris Miami Hospital | 1254235468 | 16 |
| Integris Miami Hospital | 1254235468 | 16 |
News Archive
Nano Chemical Systems announced today that it has filed a US Patent application on a breakthrough new material that exhibits light (luminescent) in the absence of heat.
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
A new World Health Organization report highlights the urgent need to reduce emissions of black carbon, ozone and methane - as well as carbon dioxide – which all contribute to climate change.
› Verified 9 days ago
| Entity Name | Integris Miami Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912508375 PECOS PAC ID: 1254235468 Enrollment ID: O20031120000383 |
News Archive
Nano Chemical Systems announced today that it has filed a US Patent application on a breakthrough new material that exhibits light (luminescent) in the absence of heat.
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
A new World Health Organization report highlights the urgent need to reduce emissions of black carbon, ozone and methane - as well as carbon dioxide – which all contribute to climate change.
› Verified 9 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
Nano Chemical Systems announced today that it has filed a US Patent application on a breakthrough new material that exhibits light (luminescent) in the absence of heat.
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
A new World Health Organization report highlights the urgent need to reduce emissions of black carbon, ozone and methane - as well as carbon dioxide – which all contribute to climate change.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Clark Osborn, MD 5300 N Independence Ave, 280, Oklahoma City, OK 73112-5556 Ph: (918) 540-7730 | John Clark Osborn, MD 310 2nd Ave Sw, 107-b, Miami, OK 74354-6743 Ph: (918) 540-7730 |
News Archive
Nano Chemical Systems announced today that it has filed a US Patent application on a breakthrough new material that exhibits light (luminescent) in the absence of heat.
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
A new World Health Organization report highlights the urgent need to reduce emissions of black carbon, ozone and methane - as well as carbon dioxide – which all contribute to climate change.
› Verified 9 days ago
Ashley Caroline Walker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 2nd Ave Sw, Suite 101, Miami, OK 74354 Phone: 918-540-7750 Fax: 918-540-7796 | |
Mr. James Craig Eaton, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7600 S. Hwy 69a, Miami, OK 74354 Phone: 918-542-1655 Fax: 918-745-3601 | |
Jequita Dawn Snyder, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Nw Veterans Blvd, Miami, OK 74354 Phone: 918-238-3074 Fax: 918-238-3076 | |
Dr. Justin Mitchell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 2nd Ave Sw, Miami, OK 74354 Phone: 918-542-6611 Fax: 918-540-7605 | |
Guy Patrick Belford, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 2nd Ave Sw, Ste 203, Miami, OK 74354 Phone: 918-540-7788 Fax: 918-540-7786 | |
Justin Walker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 2nd Ave Sw, Suite 107-a, Miami, OK 74354 Phone: 918-540-7858 Fax: 918-540-7857 | |
Marcia Kay Matthews, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 B St Sw, Miami, OK 74354 Phone: 918-542-5551 Fax: 918-542-1555 |